Cargando…
Successful regression of newly formed corneal neovascularization by subconjunctival injection of bevacizumab in patients with chemical burns
PURPOSE: To investigate the effect and timing of subconjunctival bevacizumab injection on inhibiting corneal neovascularization (CorNV) in patients after chemical burns. METHODS: Patients with CorNV secondary to chemical burns were involved. Two subconjunctival injections of bevacizumab (2.5 mg/0.1 ...
Autores principales: | Peng, Wen-yan, He, Li-wen, Yin, Xiao-fang, Zhou, Bin-Bing, Zhou, Tao, Zhou, Shi-you |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324651/ https://www.ncbi.nlm.nih.gov/pubmed/37425330 http://dx.doi.org/10.3389/fmed.2023.1210765 |
Ejemplares similares
-
Regression of Iris Neovascularization after Subconjunctival Injection of Bevacizumab
por: Ryoo, Na Kyung, et al.
Publicado: (2013) -
Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab
por: Britton, Anna Krystyna, et al.
Publicado: (2020) -
Short-term regression of corneal neovascularization with combination therapy of argon green laser photocoagulation and subconjunctival bevacizumab
por: Anand, Nandita, et al.
Publicado: (2019) -
Subconjunctival injection of antagomir-21 alleviates corneal neovascularization in a mouse model of alkali-burned cornea
por: Zhang, Yun, et al.
Publicado: (2016) -
Treatment of corneal neovascularization in ocular chemical injury with an off-label use of subconjunctival bevacizumab: a case report
por: Iannetti, Ludovico, et al.
Publicado: (2013)